Work

A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse

Year: 2006

Type: article

Study design: Clinical Trial

Source: Leukemia Research

DOI: 10.1016/j.leukres.2005.10.025

Authors: Joseph Moore, Karen Seiter, Jonathan Kolitz, Wendy Stock, Francis Giles, Matt Kalaycio, David Zenk, Guido Marcucci

Institutions: Duke Medical Center, New York Medical College, North Shore University Hospital, University of Chicago, The University of Texas MD Anderson Cancer Center, Cleveland Clinic, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1978919947

FWCI: 5.696

Cites: 23

Cited by: 79

Related to: 10